Clinical Trial Update: RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of RTA 402 (bardoxolone methyl) in advanced solid tumors and lymphoid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Malignancies
• Solid Tumors

Drugs mentioned

• RTA 402 (bardoxolone methyl)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoid Malignancies, Solid Tumors | Phase 1 | Status: COMPLETED